EU Deal Cheers Switzerland As Local Medtechs Drive For Regulatory Progress On Three Tracks

Swiss-EU Agreement Signals Likely Progress Of Medtech MRA

Switzerland’s devices MRA with the EU is fully back on the agenda following a broader, historic EU-Swiss future trade deal agreed on 20 December. Additionally, Swiss Medtech is pursuing MDR improvements with EU counterparts, and the Swiss authorities will lay the ground in 2025 to permit US FDA-approved in Switzerland.

Switzerland
• Source: Shutterstock

Renewal of the medical devices mutual recognition agreement (MRA) between Switzerland and the EU has been brought nearer following a deal agreed by Swiss president Viola Amherd and European Commission president Ursula von der Leyen on 20 December.

They jointly announced to the media the conclusion of the negotiating mandate, begun in March, to update the broader Swiss-EU trading relationship. These efforts have involved 197 meetings, but Switzerland...

More from Regulation

More from Geography